Braun-Bostich & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,357
Closed -$258K – 142
2021
Q4
$258K Buy
+3,357
New +$245K 0.06% 91

Other funds holding THC

Braun-Bostich & Associates's THC Position: Q1 2022 in Review

Braun-Bostich & Associates sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 3,357 shares — an estimated $258K sold.

Braun-Bostich & Associates first reported a position in THC in Q4 2021 and held it in 1 quarter. The position peaked at $258K in Q4 2021. 404 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • Braun-Bostich & Associates reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
  • Braun-Bostich & Associates sold 3,357 Tenet Healthcare shares in Q1 2022, an estimated $258K.
  • Braun-Bostich & Associates first reported a position in Tenet Healthcare in Q4 2021 and held it in 1 quarter.
  • Braun-Bostich & Associates's Tenet Healthcare position peaked at $258K in Q4 2021.
  • 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Braun-Bostich & Associates's 13F filing for Q1 2022, filed 13 May 2022.